Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 3/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CDC7 | O00311 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | CLK1 | P49759 | 3/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MGMT | P16455 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27631939 | 0.78 | MAPT (0.47) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| SCHEMBL3293002 | 0.77 | PDE10A (0.36) | ROCK1ALDH1A1MAPTPDE10AMEN1 | |
| SCHEMBL251218 | 0.75 | PDE10A (0.35) | ROCK1HSP90AA1ALDH1A1LMNAMAPT | |
| SCHEMBL1703418 | 0.75 | TXNRD1 (0.39) | ROCK1HSP90AA1ALDH1A1LMNAMAPT | |
| SCHEMBL8665016 | 0.75 | MAPT (0.39) | ROCK1HSP90AA1ALDH1A1LMNAMAPT | |
| Diaminopyrimidine SCHEMBL2745743 | 0.73 | ROCK1 (0.45) | ROCK1HSP90AA1GSK3BALDH1A1LMNA | |
| Diaminopyrimidine SCHEMBL29430428 | 0.73 | ROCK1 (0.45) | ROCK1HSP90AA1GSK3BALDH1A1LMNA | |
| SCHEMBL28940336 | 0.72 | PDE10A (0.33) | ROCK1ALDH1A1MAPTPDE10AMEN1 | |
| SCHEMBL17674175 | 0.71 | KDM4E (0.47) | ALDH1A1LMNAMAPTHPGDALOX15 | |
| SCHEMBL57064 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| CN-1529892-A | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | 如碧空株式会社 | 2004-09-15 | — | — | CN | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| US-5445854-A | A cured epoxy resins having glycidyl aromatic or heterocylic hydrazone monomer; high glass transition temperature, stability | THE DOW CHEMICAL COMPANY (US) | 1995-08-29 | — | — | US | claimed |
| US-20220274968-A1 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | GBIOTECH S.À.R.L. (CH) | 2022-09-01 | — | — | US | disclosed |
| CN-106279172-A | Purinone compound as inhibitors of kinases | 药品循环有限责任公司 | 2017-01-04 | — | — | CN | disclosed |
| CN-104640861-B | Purinone compounds as kinase inhibitors | 药品循环公司 | 2016-08-24 | — | — | CN | disclosed |
| EP-2099800-A1 | 7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION | Pharmacopeia, LLC (US) | 2009-09-16 | — | — | EP | disclosed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | disclosed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | disclosed |
| US-5621071-A | Mesogenic novolacs and resins | THE DOW CHEMICAL COMPANY (US) | 1997-04-15 | — | — | US | disclosed |
| US-5486580-A | Mesogenic novolacs and resins | THE DOW CHEMICAL COMPANY (US) | 1996-01-23 | — | — | US | disclosed |
| US-5466397-A | Polyethers, epoxy resins, polycarbonates | THE DOW CHEMICAL COMPANY (US) | 1995-11-14 | — | — | US | disclosed |
| US-5445854-A | A cured epoxy resins having glycidyl aromatic or heterocylic hydrazone monomer; high glass transition temperature, stability | THE DOW CHEMICAL COMPANY (US) | 1995-08-29 | — | — | US | disclosed |
| US-5279870-A | Polymerizing epoxy compound; adding curing agent | THE DOW CHEMICAL COMPANY (US) | 1994-01-18 | — | — | US | disclosed |
| US-5273792-A | Polyepoxide compound cured by an aromatic diamine having a monovalent electron-withdrawing group | THE DOW CHEMICAL COMPANY (US) | 1993-12-28 | — | — | US | disclosed |
| EP-0430143-A2 | Novel cured epoxy resins | THE DOW CHEMICAL COMPANY (US) | 1991-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220274968-A1 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | FFAR2, FFAR1, FFAR3 | ROCK1 4273/4885HSP90AA1 2944/4885GSK3B 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.